KCPG
GILD icon

Kavar Capital Partners Group’s Gilead Sciences GILD Stock Holding History

Kavar Capital Partners Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,930
Closed -$213K – 164
2021
Q4 		$213K Sell
2,930
-17,995
-86% -$1.24M 0.04% 157
2021
Q3 		$1.46M Sell
20,925
-250
-1% -$17.6K 0.33% 76
2021
Q2 		$1.46M Sell
21,175
-1,190
-5% -$79.5K 0.35% 76
2021
Q1 		$1.45M Sell
22,365
-525
-2% -$33.9K 0.39% 71
2020
Q4 		$1.33M Sell
22,890
-2,925
-11% -$176K 0.38% 68
2020
Q3 		$1.63M Buy
25,815
+420
+2% +$29.1K 0.55% 56
2020
Q2 		$1.95M Sell
25,395
-155
-0.6% -$11.9K 0.75% 46
2020
Q1 		$1.91M Sell
25,550
-10,270
-29% -$710K 0.92% 36
2019
Q4 		$2.33M Sell
35,820
-7,350
-17% -$479K 0.86% 46
2019
Q3 		$2.74M Buy
43,170
+1,260
+3% +$82.4K 1.07% 33
2019
Q2 		$2.83M Buy
41,910
+2,680
+7% +$176K 1.11% 29
2019
Q1 		$2.55M Buy
39,230
+1,350
+4% +$89.7K 1.14% 29
2018
Q4 		$2.37M Buy
37,880
+2,800
+8% +$196K 1.28% 28
2018
Q3 		$2.71M Buy
35,080
+4,925
+16% +$372K 1.34% 28
2018
Q2 		$2.14M Buy
30,155
+5,055
+20% +$357K 1.07% 37
2018
Q1 		$1.89M Buy
+25,100
New +$2M 0.99% 43
2016
Q1 		– Sell
-380
Closed -$38K – 195
2015
Q4 		$38K Hold
380
– – 0.02% 186
2015
Q3 		$37K Sell
380
-75
-16% -$8.33K 0.03% 189
2015
Q2 		$53K Buy
+455
New +$49.7K 0.04% 177
2014
Q2 		– Sell
-1,013
Closed -$71K – 245
2014
Q1 		$71K Buy
1,013
+275
+37% +$21.6K 0.06% 181
2013
Q4 		$55K Buy
+738
New +$51.4K 0.05% 186

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Kavar Capital Partners Group's GILD Position: Q1 2022 in Review

Kavar Capital Partners Group sold out of Gilead Sciences (GILD) in Q1 2022, closing a stake of 2,930 shares — an estimated $213K sold.

Kavar Capital Partners Group first reported a position in GILD in Q4 2013 and held it in 21 quarters. The position peaked at $2.83M in Q2 2019. 1,599 funds tracked by Wall St. Rank hold GILD as of Q1 2022.

  • Kavar Capital Partners Group reported no remaining Gilead Sciences position as of Q1 2022 after selling out during the quarter.
  • Kavar Capital Partners Group sold 2,930 Gilead Sciences shares in Q1 2022, an estimated $213K.
  • Kavar Capital Partners Group first reported a position in Gilead Sciences in Q4 2013 and held it in 21 quarters.
  • Kavar Capital Partners Group's Gilead Sciences position peaked at $2.83M in Q2 2019.
  • 1,599 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2022.

Based on Kavar Capital Partners Group's 13F filing for Q1 2022, filed 9 May 2022.